SBWire

mBio Diagnostics, Inc. (mBio Diagnostics) is a medical diagnostic company. The company develops a suite of multiplexed diagnostic tests. Its products include MBio CD4 System and MBio Array System. mBio Diagnostics' MBio CD4 System delivers absolute CD4 T helper cell counts at the point of care in minutes. The company's MBio Array System is a multiplexed fluorescence immunoassay system that provides the simultaneous and accurate measurement of multiple analytics from a single sample. Its products are developed for the rapid diagnosis of complex infectious diseases such as HIV and hepatitis. The company has longstanding collaboration with a team of clinical infectious disease experts at the University of California, San Diego (UCSD). mBio Diagnostics is headquartered in Boulder, Colorado, the US.

Elite Vet Products, an innovative veterinary supply company, just released their new line of veterinary surgical products that includes veterinary scrubs, veterinary gowns, wraps and drapes. The owner, John Donovin, has over 20 years of experience in the veterinary industry and has worked extensively with veterinarians to create this new line of ORGreens vet scrubs, drapes, and surgical gowns.

Straumann Holding AG (Straumann) is a medical devices company that caters to implant, restorative and regenerative dentistry. It focuses on research, development, and manufacture of dental implants, instruments, oral tissue regeneration, and prosthetics products in collaboration with leading clinics, research institutions, and universities. The company categorizes its solutions under three groups, namely, replacement solutions; digital solutions; and regenerative solutions. Straumann's product portfolio includes dental implants, active surfaces, groundbreaking materials, prosthetic components, digital solutions such as intra-oral scanning, and CADCAM, bone substitutes, and regenerative membranes. The company's products find applications in tooth replacement and restoration solutions or prevention of tooth loss. Further, it also offers a wide range of customized services that include practice building tools, business building initiatives, customer hotline. The company markets and sells its solutions and services directly to dental professionals through its subsidiaries and distribution partners in Europe, North America, Asia Pacific and other regions throughout the world. Straumann is headquartered in Basel, Switzerland.

Canada Bronchoscopes Market Outlook to 2020

Much in line with the situation the category has been witnessing since the crisis hit the Spanish economy, in 2014, spectacles recorded a poor performance with sales declining by 4% in value terms. Although the economic situation is improving from the fragile state in 2013, the average Spanish consumer is still far from feeling the security they felt prior to 2008, which is affecting the category's performance.

Molecular Detection Inc. (MDI) is medical device company. The company develops and markets diagnostic tools for detection of infectious diseases. Its product segments include Detect-Ready MRSA Swab Lysis Kit, Rotor-Gene, SmartCycler, and LightCycler. MDI is also developing Detect-Ready panels to test for the existence of microbial agents, including foodborne pathogens, C. difficile, and sexually transmitted diseases (STDs). The company markets its product through its brand name Detect-Ready. It distributes its products through distribution centers in Australia, Austria, Belgium, Germany, Ireland, Israel, Luxembourg, the Netherlands, Spain, Switzerland, and the UK. MDI is headquartered in Wayne, Pennsylvania, the US.

GlobalData's new report, "Asia-Pacific Sigmoidoscopes Market Outlook to 2020", provides key market data on the Asia-Pacific Sigmoidoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Flexible Video Sigmoidoscopes and Non-Video Sigmoidoscopes (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes).

Celiac disease has been increasing at an alarming rate. People are not very aware of this disease, and they consider it as any other normal disease. However the notion is absolutely opposite. Celiac diseases, if not treated at the right time may prove fatal. This disease is associated with digestive and autoimmune disorders that damage the lining of the small intestine when food particles which contain gluten are eaten. The damages in the intestine make it difficult to absorb the nutrients by the body. This further damages the villi that is there on the small intestine. The villi stops absorbing the nutrients from the food and if the villi, which is hair like structure in the small intestine is destroyed, it results in severe health disorder including extreme malnourishment. The best way to prevent this disease is to educate people about this and in order to do so, Canada officially made the month of October as the Celiac disease awareness month. Consequently various interest groups in the U.S. and other countries also followed the suit.

GlobalData's new report, "Germany General Surgery Outlook to 2020", provides key market data on the Germany General Surgery Procedures. The report provides procedure volumes within market segments - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.

North America Bronchoscopes Market Outlook to 2020

Brain tumor is the most devastating form of cancer and it is highly fatal if it is not diagnosed at the right time or during its initial stage. Brain tumor occurs when unwanted or multiple cells form within the brain. The common symptom of brain tumor is frequent headache, vomiting, nausea and many more such symptoms. Treating brain tumor patients are extremely difficult if it is diagnosed at its last stage, and many times the chances of survival get lesser. People are not aware of this life threatening disease. The best way to make people acquaint with the nitty and gritty of brain tumor is to create awareness of this deadly disease.

Globe Medical Tech, Inc. (GMT) is a medical device company. The company develops and markets devices for the medtech industry. It manufactures custom drug delivery solutions including syringes of all types, traditional drug delivery systems, and auto-retractable safety syringes, and prefillable safety syringes. GMT's manufacturing capabilities include injection mold making, sample and production molds, cleanroom injection molding, extrusion, over molding, material selection for FDA/CE, ultrasonic welding, radio frequency welding, packaging and sterilization, precision machining and stamping, laser engraving, CNC prototypes, software development, PC interface technology, quality assurance programs, product testing, and sterilization validation. GMT is headquartered in Houston, Texas, the US.

Mitomics Inc. (Mitomics) is a medical diagnostic device manufacturing company. The company researches and develops mitochondrial genome based products to improve clinical insight and therapeutic decisions. Its pipeline products provide solutions for prostate cancer, breast cancer, uterine cancer, cervical cancer, ovarian cancer, pancreatic cancer, endometriosis, melanoma, skin cancer and other dermatological conditions. Mitomics's Prostate Mitomic Test is a blood-based screening test for the prediction of prostate cancer following a PSA level. The company's Endometrial Mitomic Test is also blood-based screening test to identify endometriosis in patients and women of reproductive age. Mitomics is headquartered in Thunder Bay, Ontario, Canada.

GenomicTree, Inc. (GenomicTree) is a molecular diagnostic company. The company develops and commercializes diagnostic products for cancer screening and prognosis of patient outcomes. It discovers and identifies methylation biomarkers by using its Methyl DNA Scan platform technologies. GenomicTree's diagnostic products include multiplex pyroSeq test, GTPlex BRAF pyroSeq test, GTPlex KRAS pyroSeq test, GTPlex EGFR pyroSeq test, GTPlex respi pyroSeq test, GTPlex HPV pyroSeq test, OncoFinder colon cancer, OncoFinder bladder cancer, OncoFinder lung cancer and OncoFinder gastric cancer, among others. The company's services include HPV genotyping and pyrosequencing services. It operates a branch office in the US. GenomicTree is headquartered in Daejeon, Korea.

Medical machines often contain dosing and pipetting functions which require the constant movement of capillary tubes, which are only a millimetre or so in diameter. In these applications the fragile capillary tubes are often squeezed into a small bend radius which can cause damage to the tubes or blockages in the flow through them. igus has designed the e-cord micro to help in these cases. The system ensures the hoses do not fall within a pre-defined minimum bend radius of 45mm, and are also given some physical protection. The modular nature of the system and the elasticity of the material allows machine designers lots of flexibility when designing moving capillary tubes into the smallest of spaces.

On World Hospice and Palliative Care Day, My IDentity Doctor now offers diverse Medical Alert Jewelry at the most competitive prices. This is organized by a very small committee, renowned as Worldwide Palliative Care Alliance. According to the data, it is now disclosed that over 70 countries celebrate the World Hospice and Palliative Care Day. This is specifically focused on extending the care and treatment of patients and is being carried out by the highly experienced professional nurses.

GILUPI Nanomedizin (GILUPI) develops and commercializes medical devices for isolating rare cells from blood for diagnosis. It develops a new medical detector which is used in-vivo in a patient's vein for catching rare cells such as tumor cells or fetal cells. GILUPI's products are used in the therapeutic areas of diagnosing lung cancer, breast cancer, prostate cancer and prenatal diagnosis. The company has developed CellCollector for the in vivo isolation of circulating tumor cells. It has its presence in Berlin, Hamburg, Cologne, Frankfurt and Munich. The company partners with Bayer Pharma AG, University Hospital Halle, Greater Poland Cancer Centre, and University Medical Center Ulm, among others. GILUPI is headquartered in Potsdam, Germany.

Advanced Cell Diagnostics, Inc. (ACD) is a biotechnology company. The company operates in the field of molecular pathology, developing cell and tissue based diagnostic tests for personalized medicine. Its products include RNAscope probes, RNAscope assays, spotstudio software, instruments, accessory items and automated assays. ACD offers over 3,000 pre-designed single-plex target probes. The company offers services, such as start-up assay development service, biomarker validation, custom assay development and validation, CLIA-certified RNAscope services and quantitative analysis and consultative reporting. Its RNAscope in situ hybridization assays are applicable to a wide variety of research applications. ACD is headquartered in Hayward, California, the US.

HORIBA, Ltd. (Horiba) is a medical device company. The company provides an array of instruments and systems for applications ranging from in-vitro medical diagnostics, semiconductor manufacturing and metrology, automotive research and development, process and environmental monitoring, to a broad range of scientific research and development, and QC measurements. It conducts its operations under five business divisions such as Automotive Test Systems, Process and Environmental Instruments and Systems, Medical-Diagnostic Instruments and Systems, Semiconductor Instruments and Systems and Scientific Instruments and Systems. Horiba's Automotive Test Systems products include analytical emissions systems, on-board emissions systems, portable emissions systems, dilution / sampling systems, engine test systems, driveline test systems, vehicle test systems, brake test systems, wind tunnel balances, and automation systems. Horiba is headquartered in Minami-Ku, Japan.

GlobalData's new report, "India General Surgery Market Outlook to 2020", provides key market data on the India General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories - Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices.

Medikit Co., Ltd. (Medikit) is a medical device company. The company manufactures and sells vascular access medical devices. Its products include Supercath Z3V, Supercath 5 safety IV catheter, Supercath AZ, Supercath CLS, i-Works, Seiha, Parent Plus, Parent Plus 45, Slimguide, Cerulean G, Axcel guide, and Aspirarecath, among others. Medikit's products are used in the medical areas of hemodialysis, intervention and neurovascular. The company's products are used daily in operating theaters, ICUs, anesthetic departments, dialysis units and cardiology units. The company operates through its subsidiaries such as Togo Medikit Co., Ltd., Medikit Vietnam Co., Ltd. and PediaVascular Inc. Medikit is headquartered in Tokyo, Japan.

NeuroMetrix, Inc. (NeuroMetrix) is a medical device company. The company develops wearable medical technology and point-of-care diagnostics. It offers products such as SENSUS, DPNCheck and ADVANCE systems to its customers. NeuroMetrix's Sensus pain management system is an electrotherapy device designed for relief of chronic pain in the lower legs and feet. The company's DPNCheck device test system for peripheral neuropathies. Its DPNCheck device is used to detect neuropathies at an early stage and to guide treatment. NeuroMetrix's ADVANCE system is a platform for nerve conduction studies and invasive electromyography procedures. The company offers products for patients and physicians to manage chronic pain, nerve disorders, and associated sleep disturbances. NeuroMetrix is headquartered in Waltham, Massachusetts, the US.

SQI Diagnostics Inc. (SQI) is a diagnostic product company. The company offers in vitro diagnostic and pharmaceutical research products. Its products include sqidworks, sqidlite and sqid-X. SQI's sqidworks system is used in labs. The company's sqidlite is a practical benchtop system. It offers products for immunogenicity and bioanalysis, IVD and clinical, biomarkers and assay development applications. The company's products are used in analysis of therapeutic proteins, drug metabolites, subunits and oligonucleotides. It offers products to test several biomarkers and print antigen of interest. The company provides support and service to its customers. SQI is headquartered in Toronto, Ontario, Canada.

SANUWAVE Health, Inc. (SANUWAVE) is a medical device company. The company develops and commercializes wave technology devices used in various medical conditions. It develops manufactures and markets products in the areas of cardiovascular, neurological, orthopedic and advance wound care fields. SANUWAVE's pulsed acoustic cellular expression technology emits acoustic shock waves that restore the body's normal healing processes. The company's OssaTron is used for multiple orthopedic conditions which have failed to respond to conservative treatment. It offers products in three divisions such as wound care, orthopedics plastic, and cosmetic and veterinary. The company works through its business offices in the US and Europe. SANUWAVE is headquartered in Alpharetta, Georgia, the US.

GlobalData's new report, "France Biopsy Devices Market Outlook to 2020", provides key market data on the France Biopsy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biopsy Guns (Disposable and Reusable Biopsy Guns), Biopsy Needles (Core Needles, Fine Aspiration Needles (Disposable and Reusable Fine Aspiration Needles) and Disposable Vacuum-Assisted Needles), Biopsy Forceps (Disposable and Reusable Biopsy Forceps) and Biopsy Punches (Disposable and Reusable Biopsy Punches).